Weighted gene coexpression network reveals downregulation of genes in bronchopulmonary dysplasia

Wangkai Liu1, Yihua Su2, Sitao Li3

  • 1Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Pediatric Pulmonology
|October 29, 2020
PubMed

Insights

This study identified key genes (FOS, BTG2, JUN, EGR1) downregulated in premature infants with bronchopulmonary dysplasia (BPD). Their decreased expression may serve as early diagnostic biomarkers for BPD.

Area of Science:

  • Genomics
  • Neonatal Medicine
  • Pulmonology

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant cause of morbidity and mortality in premature infants.
  • Genetic factors play a complex role in BPD pathogenesis.
  • Identifying key genetic contributors is crucial for understanding and managing BPD.

Purpose of the Study:

  • To identify key genetic factors involved in the pathogenesis of bronchopulmonary dysplasia (BPD).
  • To explore gene coexpression networks associated with BPD.
  • To determine potential diagnostic biomarkers for early BPD detection.

Main Methods:

  • Weighted gene coexpression network analysis (WGCNA) was employed to construct a scale-free gene coexpression network.
  • Analysis utilized the GSE8586 dataset, including gene expression profiles from neonates with and without BPD.
  • Hub gene expression was validated in clinical samples.

Main Results:

  • A significant coexpression module downregulated in BPD was identified.
  • This module was enriched for genes involved in human T-cell leukemia virus infection and the MAPK pathway.
  • Four hub genes—FOS, BTG2, JUN, and EGR1—showed significantly decreased expression in BPD infants and were validated in clinical samples.

Conclusions:

  • Decreased expression of FOS, BTG2, JUN, and EGR1 is associated with BPD.
  • These genes represent potential biomarkers for the early diagnosis of BPD.
  • Understanding the role of these genes may lead to improved BPD management strategies.
Abstract

Related Concept Videos

Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.2K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.0K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

3.6K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
451